Clinical Trials

Text Size A A

E-Mail to a Friend






secret  Click to Play Audio


SCCA Gynecologic Cancer Clinical Trials

FDG PET for Advanced Ovarian Cancer (FHCRC-7009)
FDG PET and Biomarkers in Treatment Response in Advanced Ovarian Cancer
Status Conditions Phase Study ID
Recruiting Advanced Ovarian Cancer N/A FHCRC-7009
Summary

Study Summary: FDG PET and Biomarkers in Treatment Response in Advanced Ovarian Cancer (AOC) or primary peritoneal cancer (Stage IIIC–IV).  Goals of study are: (a) to determine the association between FDG measures of glycolysis with chemo-resistance; and (b) to determine if treatment-related changes in tumor’s FDG metabolic activity can predict treatment response, time to recurrence and disease free survival.

Recruitment Population:  Recruiting previously untreated patients with biopsy/cytology proven carcinoma of the ovary or primary peritoneum; who are candidates for neoadjuvant chemotherapy.

SCCA Referral Required: Patients need to be referred to an SCCA gynecologic oncologist for consultation in order to be considered for the study.

Participant Time Requirement:  3 separate visits to University of Washington Medical Center to have a research FDG-PET imaging scan (3 hour visit). Research FDG-PET scan occurs prior to chemotherapy cycle 1; and post cycles 1 and 3.

Study Benefits: Pretreatment PET scan includes a whole body FDG-PET scan.  Results will be provided to clinician.


Investigator
Dr. Joseph Rajendran
Location    
UW - Radiology 206-598-2383  
Eligibility Criteria (must meet the following to participate in this study)

Patients who have a new biopsy / cytology proven carcinoma of the ovary or primary peritoneum and are:
• Clinical stage IIIc–IV (by FIGO criteria) disease. Target tumor should be ≥ 1 cm.
• Candidates for neoadjuvant chemotherapy.
In addition patients must:
• Be over 18 years of age.
• Be able to give informed consent.
• Be able to lie still for the imaging procedure.
• Weigh under 350 lbs, the weight limit of the tomography table.
• Not be pregnant.
• Not have a prior ovarian cancer history, nor prior treatment or surgery for ovarian cancer.

Last Updated
February 13, 2014
Access protocol and consent forms at Fred Hutchinson Cancer Research Center
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.

Please remember:
  • Talk to your health care providers first before making decisions about your health care.
  • Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each study.